TickerFacts.

Idexx Laboratories Inc (IDXX): Total Liabilities

Annual figures by period end, from SEC filings.

$1.75B
As of 2025-12-31
$1.83B
As of 2026-06-30
-6.5%
3-year compound annual growth
+1.0%
5-year compound annual growth
+1.1%
10-year compound annual growth
$2.14B2009-12-31: $293.95M2010-12-31: $322.86M2011-12-31: $491.22M2012-12-31: $467.35M2013-12-31: $712.30M2014-12-31: $1.27B2015-12-31: $1.56B2016-12-31: $1.64B2017-12-31: $1.77B2018-12-31: $1.55B2019-12-31: $1.65B2020-12-31: $1.66B2021-12-31: $1.75B2022-12-31: $2.14B2023-12-31: $1.78B2024-12-31: $1.70B2025-12-31: $1.75B$1.75B
2009-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.75B+2.8%2026-02-20, Balance as of period end
2024-12-31$1.70B-4.4%2026-02-20, Balance as of period end
2023-12-31$1.78B-17.0%2025-02-21, Balance as of period end
2022-12-31$2.14B+22.4%2024-02-22, Balance as of period end
2021-12-31$1.75B+5.1%2023-02-16, Balance as of period end
2020-12-31$1.66B+0.4%2022-02-16, Balance as of period end
2019-12-31$1.65B+7.0%2021-02-12, Balance as of period end
2018-12-31$1.55B-12.5%2020-02-14, Balance as of period end
2017-12-31$1.77B+7.8%2019-02-15, Balance as of period end
2016-12-31$1.64B+5.1%2018-02-16, Balance as of period end
2015-12-31$1.56B+23.1%2017-02-17, Balance as of period end
2014-12-31$1.27B+77.8%2016-02-17, Balance as of period end
2013-12-31$712.30M+52.4%2015-02-17, Balance as of period end
2012-12-31$467.35M-4.9%2014-02-18, Balance as of period end
2011-12-31$491.22M+52.1%2013-02-19, Balance as of period end
2010-12-31$322.86M+9.8%2012-02-17, Balance as of period end
2009-12-31$293.95Mn/a2011-02-22, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$1.75B+2.8%
QuidelOrtho Corp (QDEL)2025-12-28$3.85B+11.9%
Lantheus Holdings, Inc. (LNTH)2025-12-31$1.14B+27.5%
Neogen Corp (NEOG)2026-05-31$1.25B-8.7%
Myriad Genetics Inc (MYGN)2025-12-31$338.60M+3.7%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$170.73M-46.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$34.81M-4.3%
Immucell Corp (ICCC)2025-12-31$15.48M-12.0%
Aspira Women's Health Inc. (AWHL)2025-12-31$12.39M+53.8%

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗